Skip to main content
Top
Published in: Abdominal Radiology 4/2015

01-04-2015

Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography

Authors: Dakun Zhang, Peng Li, Min Chen, Liping Liu, Yang Liu, Yuanyuan Zhao, Ruifang Wang

Published in: Abdominal Radiology | Issue 4/2015

Login to get access

Abstract

Objectives

To investigate the diagnostic performance of the acoustic radiation force impulse (ARFI) elastography for the assessment of the liver fibrosis in alcoholic liver disease (ALD).

Methods

We included 112 patients with ALD in whom liver biopsy, ARFI elastography, and aspartate-to-platelet ratio index (APRI) measurements were performed.

Results

ARFI elastography correlated significantly with histological fibrosis (r = 0.685, P < 0.001) in patients with ALD. The diagnostic accuracies expressed as areas under receiver operating characteristic (AUROC) curves for ARFI elastography and APRI were 0.846 and 0.763 for the diagnosis of significant fibrosis (S ≥ 2), 0.875 and 0.688 for the diagnosis of severe fibrosis (S ≥ 3), and 0.893 and 0.648 for the diagnosis of liver cirrhosis, respectively. The AUROC values of ARFI elastography were significantly better than those of APRI for predicting severe fibrosis (P = 0.02) and cirrhosis (P = 0.04). The optimum cutoff values for ARFI elastography were 1.33 m/s for S ≥ 2, 1.40 m/s for S ≥ 3, and 1.65 m/s for S = 4 in patients with elevated alanine aminotransferase (ALT) levels; these decreased to 1.24 m/s for S ≥ 2, 1.27 m/s for S ≥ 3, and 1.41 m/s for S = 4 in patients with normal ALT.

Conclusion

ARFI elastography is an acceptable method for predicting the severity of fibrosis in patients with ALD. ARFI elastography is influenced by elevated aminotransferase levels in ALD.
Literature
1.
go back to reference World Health Organization (2011) Global status report on alcohol and health. Geneva: World Health Organization, p 286 World Health Organization (2011) Global status report on alcohol and health. Geneva: World Health Organization, p 286
3.
go back to reference Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5(4):301–304PubMed Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5(4):301–304PubMed
4.
go back to reference Regev A, Berho M, Jeffers LJ, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618CrossRefPubMed Regev A, Berho M, Jeffers LJ, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618CrossRefPubMed
5.
go back to reference Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis. Hepatology 38(6):1449–1457CrossRefPubMed Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis. Hepatology 38(6):1449–1457CrossRefPubMed
6.
go back to reference Ferraioli G, Tinelli C, Dal Bello B, et al. (2013) Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol 19(1):49–56CrossRefPubMedCentralPubMed Ferraioli G, Tinelli C, Dal Bello B, et al. (2013) Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol 19(1):49–56CrossRefPubMedCentralPubMed
7.
go back to reference Morikawa H, Fukuda K, Kobayashi S, et al. (2011) Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. J Gastroenterol 46(3):350–358CrossRefPubMed Morikawa H, Fukuda K, Kobayashi S, et al. (2011) Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. J Gastroenterol 46(3):350–358CrossRefPubMed
8.
go back to reference Sporea I, Sirli R, Bota S, et al. (2011) Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis. World J Radiol 3(7):188–193CrossRefPubMedCentralPubMed Sporea I, Sirli R, Bota S, et al. (2011) Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis. World J Radiol 3(7):188–193CrossRefPubMedCentralPubMed
9.
go back to reference Ferraioli G, Parekh P, Levitov AB, Filice C (2014) Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med 33(2):197–203CrossRefPubMed Ferraioli G, Parekh P, Levitov AB, Filice C (2014) Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med 33(2):197–203CrossRefPubMed
10.
go back to reference Friedrich-Rust M, Buggisch P, de Knegt RJ, et al. (2013) Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat 20(4):240–247CrossRefPubMed Friedrich-Rust M, Buggisch P, de Knegt RJ, et al. (2013) Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat 20(4):240–247CrossRefPubMed
11.
go back to reference Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L (2013) Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol 39(11):1942–1950CrossRefPubMed Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L (2013) Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol 39(11):1942–1950CrossRefPubMed
12.
go back to reference Tapper EB, Cohen EB, Patel K, et al. (2012) Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 10(8):932–937CrossRefPubMedCentralPubMed Tapper EB, Cohen EB, Patel K, et al. (2012) Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 10(8):932–937CrossRefPubMedCentralPubMed
13.
go back to reference Fung J, Lai CL, Cheng C, et al. (2011) Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 106(3):492–496CrossRefPubMed Fung J, Lai CL, Cheng C, et al. (2011) Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 106(3):492–496CrossRefPubMed
14.
go back to reference Nightingale K, Soo MS, Nightingale R, Trahey G (2002) Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol 28:227–235CrossRefPubMed Nightingale K, Soo MS, Nightingale R, Trahey G (2002) Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol 28:227–235CrossRefPubMed
15.
go back to reference Theise ND (2007) Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 20(suppl):S3–S14CrossRefPubMed Theise ND (2007) Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 20(suppl):S3–S14CrossRefPubMed
16.
go back to reference Colloredo G, Guido M, Sonzogni A, Leandro G (2003) Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39(2):239–244CrossRefPubMed Colloredo G, Guido M, Sonzogni A, Leandro G (2003) Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39(2):239–244CrossRefPubMed
17.
go back to reference Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2(2):165–173CrossRefPubMed Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2(2):165–173CrossRefPubMed
18.
go back to reference Friedman LS (2004) Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep 6(1):30–36CrossRefPubMed Friedman LS (2004) Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep 6(1):30–36CrossRefPubMed
19.
go back to reference Sporea I, Bota S, Peck-Radosavljevic M, et al. (2012) Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol 81(12):4112–4118CrossRefPubMed Sporea I, Bota S, Peck-Radosavljevic M, et al. (2012) Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol 81(12):4112–4118CrossRefPubMed
20.
go back to reference Ye XP, Ran HT, Cheng J, et al. (2012) Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B. J Ultrasound Med 31(8):1245–1253PubMed Ye XP, Ran HT, Cheng J, et al. (2012) Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B. J Ultrasound Med 31(8):1245–1253PubMed
21.
go back to reference Nguyen-Khac E, Chatelain D, Tramier B, et al. (2008) Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28(10):1188–1198CrossRefPubMed Nguyen-Khac E, Chatelain D, Tramier B, et al. (2008) Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28(10):1188–1198CrossRefPubMed
22.
go back to reference Nahon P, Kettaneh A, Tengher-Barna I, et al. (2008) Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 49(6):1062–1068CrossRefPubMed Nahon P, Kettaneh A, Tengher-Barna I, et al. (2008) Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 49(6):1062–1068CrossRefPubMed
23.
go back to reference Bota S, Herkner H, Sporea I, et al. (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33(8):1138–1147CrossRefPubMed Bota S, Herkner H, Sporea I, et al. (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33(8):1138–1147CrossRefPubMed
24.
go back to reference Boursier J, Isselin G, Fouchard-Hubert I, et al. (2010) Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol 22(9):1074–1084CrossRefPubMed Boursier J, Isselin G, Fouchard-Hubert I, et al. (2010) Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol 22(9):1074–1084CrossRefPubMed
25.
go back to reference Friedrich-Rust M, Wunder K, Kriener S, et al. (2009) Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252(2):595–604CrossRefPubMed Friedrich-Rust M, Wunder K, Kriener S, et al. (2009) Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252(2):595–604CrossRefPubMed
26.
go back to reference Foucher J, Castera L, Bernard PH, et al. (2006) Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18(4):411–412CrossRefPubMed Foucher J, Castera L, Bernard PH, et al. (2006) Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18(4):411–412CrossRefPubMed
27.
go back to reference Yoon KT, Lim SM, Park JY, et al. (2012) Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci 57(6):1682–1691CrossRefPubMed Yoon KT, Lim SM, Park JY, et al. (2012) Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci 57(6):1682–1691CrossRefPubMed
28.
go back to reference Bota S, Sporea I, Peck-Radosavljevic M, Sirli R, et al. (2013) The influence of aminotransferase levels on liver stiffness assessed by acoustic radiation force impulse elastography: a retrospective multicentre study. Dig Liver Dis 45(9):762–768CrossRefPubMed Bota S, Sporea I, Peck-Radosavljevic M, Sirli R, et al. (2013) The influence of aminotransferase levels on liver stiffness assessed by acoustic radiation force impulse elastography: a retrospective multicentre study. Dig Liver Dis 45(9):762–768CrossRefPubMed
Metadata
Title
Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography
Authors
Dakun Zhang
Peng Li
Min Chen
Liping Liu
Yang Liu
Yuanyuan Zhao
Ruifang Wang
Publication date
01-04-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0154-5

Other articles of this Issue 4/2015

Abdominal Radiology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.